Loading

JSM Communication Disorders

The Lidcombe Program via webcam: a case study

Case Report | Open Access

  • 1. Sabine Van Eerdenbrugh, Speech-Language Therapy, Thomas More College of Applied Sciences, Belgium
  • 2. Van Borsel, John, Speech-Language Therapy, University of Ghent, Belgium
+ Show More - Show Less
Corresponding Authors
Sabine Van Eerdenbrugh, Sint-Andriesstraat 2, 2000 Antwerp, Belgium
Abstract

The Lidcombe Program is a treatment for early stuttering. It has been thoroughly investigated in its standard, clinical format. An Australian randomized controlled trial that compared the clinical and a webcam format of the Lidcombe Program resulted in similar outcome. The webcam format of the Lidcombe Program is to our knowledge not yet investigated in other trials. With this case study we wanted to assess the viability of the Lidcombe Program via webcam outside of Australia, in our Belgian context. F. was a 3-year-and-4-month-old boy who stuttered for four months at the time of treatment commencement. The intake session was a physical session. The treatment sessions were delivered via webcam. Severity ratings after 9 and 18 months were the primary outcome; number of treatment sessions and number of weeks to complete Stage 1 were the secondary outcome. F. started with a mean severity rating of 2.6 pre-treatment. The stuttering decreased to 0.6 at 9 months post-treatment (x2) and 0 at 18 months after treatment. He needed 33 weeks to complete Stage 1. The number of sessions to complete Stage 1 was 18. This outcome was below the mean results from the webcam group of the trial of Bridgman et al. The number of weeks was above the median number of weeks of the Bridgman et al. trial, but the number of treatment sessions was lower because after three webcam sessions with a weekly interval, sessions were planned with a fortnightly interval.

Citation

Van Eerdenbrugh S, Van Borsel J (2021) The Lidcombe Program via webcam: a case study. JSM Communication Dis 4(1): 1012.

Keywords

Stuttering, Preschool child, Webcam, The Lidcombe Program, Case study

ABBREVIATIONS

%SS: Percentage Syllables Stuttered; SR: Severity Rating

INTRODUCTION

Stuttering or stammering is characterized by the World Health Organization WHO, [1] as: Speech that is characterized by frequent repetition or prolongation of sounds or syllables or words, or by frequent hesitations or pauses that disrupt the rhythmic flow of speech. It should be classified as a disorder only if its severity is such as to markedly disturb the fluency of speech.

Developmental stuttering typically appears in children at preschool age, most frequently between 25 and 42 months [2]. In their longitudinal community cohort, Reilly et al. [10] reported a cumulative incidence at 4 years of 11.2%, which is higher than previously reported incidences of about 8% [3]. Different research methods account for the variation in incidence numbers.

The majority of preschool children recover from stuttering. Some of them without intervention (called natural or spontaneous recovery) and some of them with intervention. Some factors can predict the possibility of recovery for a number of children. For example, being a boy or having a family member who stutters indicates a lower chance on recovery [4]. Sugathan and Maruthy [5] found four factors that are statistically related to stuttering recovery at one year post-onset: phonological abilities, articulatory rate, change in the pattern of disfluencies and the trend in stuttering severity in the year after stuttering onset. Singer et al. [6] found that a less optimal attention span was related to stuttering recovery. In a longitudinal community cohort study in Australia [2], predictors for recovery included gender, stuttering incidence in the family, language skills, temperament, quality of life of the child and non-verbal cognition. The predictive power of these factors, however, is limited to a part of stuttering children. So in the clinic, a speech-language therapist (SLT) will take them into consideration, but knows that they are nonconclusive for taking a decision about starting treatment or not. Yairi and Ambrose [4] found that 74% of children recover naturally from stuttering within four years post-onset. It must be noted, however, that they provided parents with “a brief, unbiased review of several factors frequently cited as potentially beneficial for children who stutter, such as slow speech, not interrupting and avoiding negative consequences of the child’s speech” [4]. In the first 19 months post-onset, only a small number of children, reported around 6%, recover from stuttering [4,7]. Knowing that only a minority of children recover within the first 19 months post-onset and knowing that preschool children who stutter have more difficulty in emotional, social and behavioral development and a lower well-being [8,9], justifies the decision to treat preschool children for stuttering timely after onset and not to wait for multiple years for naturally recovery to occur.

Recovery from stuttering with intervention is reported in several randomized controlled trials in which the control group received temporarily no treatment [10] or received the available evidence-based treatment, the Lidcombe Program [11]. More research is necessary, but studies so far indicate that stuttering can be controlled with treatment in most preschool children. Systematic reviews conclude that most studies in preschool children have been conducted with the Lidcombe Program[12-14].

The Lidcombe Program is a behavioral program for preschool children who stutter [15,16]. The program consists of Stage 1, in which (near) zero levels of stuttering are obtained, and Stage 2, in which the (near) zero levels of stuttering are maintained. In Stage 1, parent(s) and child visit the SLT weekly for a (initially) one hour visit. During that visit, it is mainly the parent(s) that is guided by the SLT in [1] identifying and evaluating the stuttering, [2] organizing the practice conversations which are daily implemented at home by the parent(s) and [3] providing verbal contingencies. These verbal contingencies are mainly verbal encouragements that are provided for the stutter-free speech of the child. To keep track of the stuttering development, a severity rating scale is used. This 10-point scale starts at 0 (for no stuttering) and increases to 9 (for extremely severe stuttering). Parents are asked to record a score for the child’s stuttering each day. The scores register the development of the stuttering and allow parents and SLT to ‘understand’ the stuttering behavior. It also enhances treatment planning. In summary, the stuttering severity ratings are indispensable in the program. Parents also implement a 10-minute practice conversation each day at home. Initially, when parent(s) and child are still learning about stuttering, these practice conversations can be quite structured. The main goal of the practice conversations is to give the child the chance to practice stutter-free speech. Hence, a situation to obtain stutter-free speech is created based on the needs of the child at that moment. Once parent(s) and child feel more comfortable and the stuttering is decreasing, the practice conversations mirror everyday conversations between parent(s) and child. It is vital that parents demonstrate in the clinic session with the SLT how they implement these practice conversations at home with their child. The SLT guides parents in the organization of the practice conversations for example with the choice of activity, the location and the time of the day. Organizing the daily practice conversations in a way that they are effective is a difficult task and parent(s) need decent guidance in this. Parents also provide verbal contingencies for the child’s speech outside the practice conversations after some time in the treatment process. Initially they only provide verbal contingencies during the practice conversations and only for stutter-free speech. When the child responds well to them and when the stuttering decreases, verbal contingencies are occasionally also provided for stuttering, and also before outside of the practice conversations. The SLT guides the parent(s) with the types, the frequency and the timing of the verbal contingencies.

When Stage 1 criteria are met, The Lidcombe Program proceeds to Stage 2. The criteria for Stage 2 are: [1] only daily stuttering severity ratings of 0 and 1 for three consecutive weeks with mostly 0, [2] stuttering severity ratings of 0 or 1 during the clinic sessions for three consecutive weeks. The SLT has the option to record % Stuttered Syllables (%SS) for the conversations with the child during the clinic sessions. %SS is measured by dividing the number of syllables that are stuttered by the total number of syllables [17]. The clinic sessions during Stage 2 are scheduled with intervals of 2 weeks, 2 weeks, 4 weeks, 4 weeks, 8 weeks, 8 weeks and 16 weeks when the speech contains (near) zero levels of stuttering. During Stage 2, it is necessary that parents know what to do in case the stuttering returns, as stuttering is known to be a relapse-prone disorder. If the stuttering returns, additional visits may be necessary

There is ample evidence for the effect of the treatment and the positive psycho-social relationship between parent and child after completing the Lidcombe Program. The efficaciousness and effectiveness of the Lidcombe Program have been repeatedly shown in Phase III studies (including randomized control trials [10,11] and a Phase IV study translational study [18]. Jones et al. [10] conducted a randomized control trial with 54 children, in which 29 children received the Lidcombe Program after randomization and 25 received the Lidcombe Program nine months after randomization (the control group). This study revealed that the children who received the Lidcombe Program were seven times more likely to achieve (near) zero levels of stuttering nine months after randomization than the children who did not receive treatment for that period of time. The children from this study were contacted again five years after randomization [19]. Most children (80%) maintained their (near) zero levels of stuttering.

The Lidcombe Program manual recommends weekly clinic sessions. A recent study [20] looked at alternatives for weekly clinic visits. The preschool children who stutter and their parent came to the clinic twice weekly (N = 6), weekly (N = 7) and fortnightly (N = 8) for Lidcombe Program delivery. Ten more children were intended to receive treatment but dropped out or were withdrawn from the mainly they did not complete Stage 1 within 6 months. The twice weekly group needed a median of 29 clinic sessions over a period of 20 weeks. The weekly group needed a median of 23 clinic sessions over a period of 23 weeks. The fortnightly group needed a median of 13 clinic sessions over a period of 24 weeks. No significant differences were observed between the mean %SS in each group at 9 months posttreatment. The high drop-out was mainly situated in the twice weekly group and suggests that not all families benefitted from more than weekly visits. The results from this study also indicate that delivering the Lidcombe Program with fortnightly clinic sessions succeeded in achieving similar treatment outcomes at a lower cost for the patient and the health system. More research is necessary to confirm these findings.

The Lidcombe Program is most often applied in its standard, clinic-based format. Webcam delivery is also possible and seems to yield similar results. In a study by Bridgman et al. [21], 49 Australian preschool children were randomized into a group who received the clinic-based format (N = 24) and a group who received the webcam format (N = 25). Results from this trial indicate no difference between %SS at nine months posttreatment and the number of treatment sessions to complete Stage 1. All parents reported that webcam delivery was noninvasive and they would do this again if needed [22]. Nearly all (85%) agreed that attending sessions was easier and 81% reported that webcam quality was sufficient. They described webcam delivery as convenient, comfortable and as a more natural option for their child.

Studies with the Lidcombe Program in the standard clinical format have repeatedly been replicated in other countries than its originating country Australia with successful results [11,23]. To our knowledge, studies with the Lidcombe Program in webcam delivery have not yet been replicated. We therefore wanted to know whether a webcam delivery of the Lidcombe Program would be feasible in Belgium. As we merely wanted an indication whether the Lidcombe Program could be delivered via webcam in the Belgian context, it was not deemed necessary to conduct an extensive randomized controlled trial, and a case study design was opted for. In the past, both authors applied the same procedure to the clinic-based format of the Lidcombe Program [24]. With this article, we want to answer the research question: Is webcam delivery of the Lidcombe Program viable in Belgium too?

CASE PRESENTATION

This study was approved by the Ethic Committee of the University of Ghent, Belgium. The administered research design was a prospective case study. The CARE-checklist [25] was used for writing this case report.

The participant was F., a 3-year-and-4-month-old boy at the time of treatment commencement. Stuttering onset was sudden, a week before F.’s 3rd birthday. The stuttering consisted mainly of repetitions at the beginning of sentences. These were frequently produced but without tension. The stuttering was more severe towards the end of the week. There was no known family history of stuttering.

F. had tubes in his eardrum which were removed a few months before his 3rd birthday. He is the youngest of a family with two parents, a mother and a father, and with an older brother and sister (each 2 years apart). F. started preschool Six months before his 3rd birthday for 4.5 days a week, according to the normal preschool schedule in Belgium (half a day on Wednesdays). His speech contained incidental instances of incompletely developed phonology (cluster reduction of clusters with /r/), indicating a gradual breakthrough of the developed speech. This process was adequate for his age.

Soon after stuttering onset, F.’s family contacted the first author (SLT) for advice. The SLT planned a physical intake session with the parents and child and provided basic information about stuttering close to onset. The parents were sufficiently reassured and the child’s behavior was not alarming at that point in time. Therefore, the SLT suggested to first actively monitor the stuttering behavior for a few weeks. The SLT explained the 10-point severity rating scale and asked the parents to record severity ratings for a few weeks. Every 4 weeks the SLT contacted F.’s mum to talk about the stuttering development. The frequency of the stuttering moments was stable for several weeks, but after four months, F.’s speech started to contain occasional prolongations and blocks as well. At that point, the SLT and F.’s parents decided that it was better to commence treatment.

The Lidcombe Program was delivered according to the then available Lidcombe Program guide [26] but with the necessary modifications to allow webcam delivery. For example, the agreements used by Bridgman et al. [22] were accepted by the parent(s): siblings are not present during the first sessions; parent(s) and child are ready for the session (been to the toilet, being dressed, ...); parent(s) have the severity ratings and activities for practice conversations by hand; the parents’ mobile telephone(s) are turned off; parent(s) are attending the session with their child. Three sessions were scheduled with a weekly interval, but then it was not possible for the parent(s) to further schedule sessions with a weekly interval. From then onwards, the sessions were scheduled with a fortnightly interval. The measures for the case study were limited to severity ratings, as prescribed by the Lidcombe Program guide. The conversations between the child and the SLT during the webcam sessions were a short (15 minute) and selective moment with the child and did not represent the child’s speech of the days in between webcam sessions. Therefore, a mean of the daily severity ratings per week was used as measure in this study. Agreement between severity rating of the parent and SLT was established at the beginning of each webcam session. The SLT confirmed that the parent, who registered the daily severity rating, attributed them accurately.

Both parents were trained in using the severity ratings scale and both parents were trained in providing the verbal contingencies. However, F.’s mum was the leading parent throughout the treatment process. One webcam session, at the beginning of the treatment process, occurred with F.’s dad. As it was difficult to organize sessions with him present, only F.‘s mum attended the webcam sessions after that.

The typical webcam visit contained [1] a conversation or game with F. and the SLT, with the help from the mum; [2] mum demonstrating how verbal contingencies were provided and how practice conversations were implemented with F. daily; [3] F. went playing downstairs with his siblings while the SLT registered the severity ratings and discussed progress of the stuttering and the treatment in general; [4] F. greeting (with a short conversation sometimes) the SLT.

Webcam sessions took 45 to 60 minutes in Stage 1 and 30 minutes in Stage 2. Activities for the initial conversation were picture books and then barrier games later on. With barrier games, the two parties have the same pictures or other resources. The two parties were F. and the SLT. Sometimes F. gave instructions to the SLT to put something on a scene or to choose pictures for a sequence. They then checked if the instructions were followed correctly. Other times, the SLT gave instructions and then asked F. to describe what he had put down (for example what the sequence was). In both cases, F. did most of the talking. Other activities were a ‘Headband’ game where for example F. put a picture in a bandana around his head and asked questions to guess what the item was. When the SLT put the picture in the bandana, she asked if F. could give some clues. Again, F. did most of the talking.

The mean severity ratings from the daily recording at home at pre-treatment, 9 and 18 months post-treatment were compared to the mean severity ratings reported in the webcam trial with the Lidcombe Program by Bridgman et al. [21]. Also the number of sessions and the number of weeks to complete Stage 1 were compared.

The mean severity ratings at pre-treatment, 9 and 18 months post-treatment are presented in (Tables 1,2).

 

DISCUSSION

Also, webcam visits were scheduled on a fortnightly basis and not on a weekly basis. The Lidcombe Program guideline was followed but the clinic sessions could not be scheduled on a weekly basis. After the first three weekly sessions, clinic sessions were scheduled fortnightly. Koushik et al. [20] showed that preschool children who stutter did not need longer treatment with fortnightly clinic sessions than those with weekly clinic sessions. They registered treatment duration between 15 and 46 weeks. F. needed 33 weeks to complete Stage 1, which is within the same range. It took F. longer than the median number of weeks in the study of Bridgman et al. [21] to complete Stage 1 but looking at the entire group, 40% of children in Bridgman’s webcam group [22] needed more than 33 weeks to complete Stage 1. From a translational study in Australia, that is, a study conducted in the daily practice of Australian SLTs, the reported range of weeks to complete Stage 1 was 4 to 25 with 25 not being the absolute limit as the study was not completed at the time of writing the study results [18] given the fortnightly scheduling of the webcam visits, he needed less visits than the mean number of visits in the study of Bridgman et al. [21].

A frequently used measure is %SS or severity rating at 9-months in treatment. It is important to realize that nine months in treatment is an arbitrary time point, which could sometimes coincide with a period of relapse. In F.’s case, the 9-months’ time point was a realistic representation of the treatment progress at that point in time. Six weeks later however, a relapse occurred and severity ratings were much higher again.

F.’s mum asked for a face-to-face visit during the first relapse. She needed confirmation and for her it was important that the SLT saw F. for a longer period than the 15 minutes during the webcam session. The SLT organized a face-to-face visit. They only needed this once. It indicated the need for more than webcam support at difficult times during the treatment.

Despite being a case study, our results generate support for delivering the Lidcombe Program via webcam outside of Australia, in the Belgian context. The Bridgman et al. study [21] was a randomized controlled trial under controlled conditions. This case study reflects daily practice as it allowed modifications on the Lidcombe Program guideline for webcam delivery. Also, webcam visits were scheduled on a fortnightly basis and not on a weekly basis. This case study illustrated a rather longer treatment process of the Lidcombe Program with successful outcome. The fact that weekly webcam visits were not possible to maintain, reflects a frequently occurring challenge of the time constraints that parents encounter [27-29]. A case study also has its limitations. Obviously, results from a single case cannot be generalized without caution.

In conclusion, this study illustrates that webcam delivery of the Lidcombe Program is successful in a single case outside of Australia. This study was planned and implemented before the Covid-19 pandemic and may serve as an inspiration for SLTs for treatment delivery nowadays.

Table 1: Mean severity ratings in this study and the webcam study of Bridgman.

Study Mean SR pretreatment 
(N = 25 in 
Bridgman et 
al.)
Mean SR 9 
months posttreatment (N = 
23 in Bridgman 
et al.)
Mean 18 
months posttreatment 
(N = 16 in 
Bridgman et 
al.)
Bridgman 3.8 (2 – 9) 1.7 (1 – 5) 0.8 (°)
Case study 2.6 0.6 0

Table 2: Number of treatment sessions and weeks to complete Stage 1 compared to the Bridgman.

Study Treatment sessions Stage 1 (N) Weeks Stage 1 (N)
Bridgman 23.4 (9 – 46) 25 (12 – 56)
Case study 18 33

 

REFERENCES

1. World Health Organisation. International Classification of Disease-10 (ICD-10) 2010.

2. Reilly S, Onslow M, Packman A, Cini E, Conway L, et al. Natural History of Stuttering to 4 Years of Age: A Prospective Community-based Study. Pediatrics.2013; 132(3): 460–467.

3. Yairi E, Ambrose N. Epidemiology of Stuttering: 21st Century Advances. J Fluency Disord. 2013; 38(2): 66-87.

4. Yairi E, Ambrose NG. Early Childhood Stuttering I: Persistency and Recovery Rates. J Speech Lang Hear. 199; 42(5): 1097-1112.

5. Sugathan N, Maruthy S. Predictive Factors for Persistence and Recovery of Stuttering in Children: A Systematic Review. Int J Speech Lang. 2020; 1-13.

6. Singer CM, Walden TA, Jones RM. Attention, Speech-Language Dissociations, and Stuttering Chronicity. Am J Speech Lang Pathol. 2020; 29(1): 157-167.

7. Carey B, Onslow M, O’Brian S. Natural recovery from stuttering for a clinical cohort of pre-school children who received no treatment. Int J Speech Lang. 2020; 1-9.

8. Briley PM, Ellis C. Behavioral, Social, and Emotional Well-being in Children who Stutter: The Influence of Race- ethnicity. Logoped Phoniatr Vocol. 2020; 1-9.

9. McAllister J. Behavioural, Emotional, and Social Development of Children who Stutter. J Fluency Disord. 2016; 50: 23-32.

10. Jones M, Onslow M, Packman A, Williams S, Ormond T, et al. Randomised Controlled Trial of the Lidcombe program of Early Stuttering Intervention. BMJ. 2005; 331:659–661.

11. De Sonneville-Koedoot C, Stolk E, Rietveld T, Franken MC. Direct versus Indirect Treatment for Preschool Children who Stutter: The restart Randomized Trial. PLoS One. 2015; 10(7): e0133758.

12. Baxter S, Johnson M, Blank L, Cantrell A, Brumfitt S, et al.. The state of the art in non-pharmacological interventions for developmental stuttering. Part 1: a systematic review of effectiveness. Int J Lang Comm Dis. 2015; 50 (5): 676–718 

13. Bothe AK, Davidow JH, Bramlett RE, Ingham RJ. Stuttering treatment research 1970-2005: I. Systematic review incorporating trial quality assessment of behavioral, cognitive, and related approaches. Am J Speech Lang Pathol.2006; 15(4): 321-341.

14. Nye C, Vanryckeghem M, Schwartz JB, Herder C, Turner HM, et al. Behavioral Stuttering Interventions for Children and Adolescents: A Systematic Review and Meta-analysis. J Speech Lang Hear 2013; 56(3): 921-932.

15. Onslow M, Webber M, Harrison E, Arnott S, Bridgman K, et al. The Lidcombe Program treatment guide 2020.

16. Onslow, M, Packman, A, Harrison, E. The Lidcombe Program of Early Stuttering Intervention: A Clinician’s Guide 2003. Pro-Ed.

17. Bridgman K, Onslow M, O’Brian S, Block,S. Changes to Stuttering Measurement during the Lidcombe Program Treatment Process. Asia Pac J Speech Lang Hear. 2011; 14(3): 147-152.

18. O’Brian S, Iverach L, Jones M, Onslow M, Packman A, et al. Effectiveness of the Lidcombe Program for Early Stuttering in Australian Community Clinics. Int J Speech Lang. 2013; 15(6): 593-603.

19. Jones M, Onslow M, Packman A, O’Brian S, Hearne A, et al. Extended Follow-up of a Randomized Controlled Trial of the Lidcombe Program of Early Stuttering Intervention. Int J Lang Comm Dis. 2008; 43(6): 649-661.

20. Koushik S, Hewatt S, Onslow M, Shenker R, Jones M, et al. Three Lidcombe Program Clinic Visit Options: A Phase II Trial. J Commun Disord. 2019; 82 : 105919. Van Eerdenbrugh S, Van Borsel J (2021) The Lidcombe Program via webcam: a case study. JSM Communication Dis 4(1): 1012. Cite this article

21. Bridgman K, Onslow M, O’Brian S, Jones M, Block S. Lidcombe Program Webcam Treatment for Early Stuttering: A Randomized Controlled Trial. J Speech Lang Hear. 2016; 59(5): 932-939.

22. Bridgman, K. Webcam Delivery of the Lidcombe Program for Preschool Children who Stutter: A Randomised Controlled Trial. 2014;

23. Lattermann C, Euler HA, Neumann K. A Randomized Control Trial to Investigate the Impact of the Lidcombe Program on Early Stuttering in German-speaking Preschoolers. J Fluency Disord. 2008; 33(1): 52-65.

24. Van Eerdenbrugh S, Van Borsel J. Logopedie in een meertalige context: een gevalstudie met het Lidcombe Program. Logopedie. 2016; 29(5): 25-34

25. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development 2020.

26. Onslow M, Webber M, Harrison E, Arnott S, Bridgman K, et al. The Lidcombe Program treatment guide 2019.The Lidcombe Program treatment guide.

27. Goodhue R, Onslow M, Quine S, O’Brian S, Hearne A. The Lidcombe Program of Early Stuttering Intervention: Mothers’ Experiences. J Fluency Disord. 2010; 35(1): 70-84.

28. Hayhow R. Parents’ Experiences of the Lidcombe Program of Early Stuttering Intervention. Int J Speech Lang. 2009; 11(1): 20-25.

29. Van Eerdenbrugh S, Packman A, O’Brian S, Onslow M. Challenges and Strategies for Speech-Language Pathologists Using the Lidcombe Program for Early Stuttering. Am J Speech Lang Pathol. 2018; 27(3S): 1259-1272

Van Eerdenbrugh S, Van Borsel J (2021) The Lidcombe Program via webcam: a case study. JSM Communication Dis 4(1): 1012.

Received : 11 Feb 2021
Accepted : 01 Mar 2021
Published : 03 Mar 2021
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X